Piperacillin pharmacokinetics in subjects with chronic renal failure
- PMID: 6454382
- PMCID: PMC181452
- DOI: 10.1128/AAC.19.3.450
Piperacillin pharmacokinetics in subjects with chronic renal failure
Abstract
The pharmacokinetic parameters of piperacillin sodium were studied in eight volunteer subjects with chronic renal failure. Subjects were given a single 30-min intravenous infusion of 70 mg/kg (lean body weight) on their off-dialysis day. Blood was drawn from the contralateral arm at 15 and 30 min and 1, 3, 6, 9, and 12 h from the start of the infusion. Kinetic parameters were determined during the elimination phase with a one-compartment open model for linear kinetics. The following pharmacokinetic parameters (mean +/- standard deviation) were determined for the eight subjects: elimination half-life = 3.33 +/- 0.99 h, elimination rate constant = 0.22 +/- 0.06 h-1, apparent volume of distribution = 0.18 +/- 0.05 liters per kg, and total body clearance = 0.041 +/- 0.019 liters per kg/h. The mean peak serum concentration was 372 +/- 125 microgram/ml, and mean trough at 12 h was 39 +/- 27 microgram/ml. A dose of 70 mg/kg (lean body weight) or a dose of 4 g appears to provide adequate serum concentrations against susceptible organisms for a 12-h interval. No adverse reactions were noted in any subject throughout the study.
Similar articles
-
Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.Antimicrob Agents Chemother. 1979 Dec;16(6):788-91. doi: 10.1128/AAC.16.6.788. Antimicrob Agents Chemother. 1979. PMID: 533260 Free PMC article.
-
Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.Antimicrob Agents Chemother. 1981 Feb;19(2):279-83. doi: 10.1128/AAC.19.2.279. Antimicrob Agents Chemother. 1981. PMID: 6214987 Free PMC article.
-
Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.Antimicrob Agents Chemother. 1980 Mar;17(3):344-9. doi: 10.1128/AAC.17.3.344. Antimicrob Agents Chemother. 1980. PMID: 7425600 Free PMC article.
-
Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions.Pharmacotherapy. 1982 Nov-Dec;2(6):287-99. doi: 10.1002/j.1875-9114.1982.tb03202.x. Pharmacotherapy. 1982. PMID: 6220262 Review.
-
Overview of acylureidopenicillin pharmacokinetics.Scand J Infect Dis Suppl. 1981;29:33-48. Scand J Infect Dis Suppl. 1981. PMID: 7031864 Review.
Cited by
-
Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure.Infection. 2009 Aug;37(4):374-6. doi: 10.1007/s15010-009-8373-3. Epub 2009 Jun 4. Infection. 2009. PMID: 19499182 No abstract available.
-
Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients.Antimicrob Agents Chemother. 1982 Sep;22(3):488-92. doi: 10.1128/AAC.22.3.488. Antimicrob Agents Chemother. 1982. PMID: 6215894 Free PMC article.
-
Pharmacokinetics of piperacillin in subjects with various degrees of renal function.Antimicrob Agents Chemother. 1983 Jun;23(6):881-7. doi: 10.1128/AAC.23.6.881. Antimicrob Agents Chemother. 1983. PMID: 6225390 Free PMC article.
-
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002. Drugs. 1984. PMID: 6391888 Review.
-
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.Crit Care. 2010;14(4):R126. doi: 10.1186/cc9091. Epub 2010 Jul 1. Crit Care. 2010. PMID: 20594297 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical